Targeted silencing of SOX2 by an artificial transcription factor showed antitumor effect in lung and esophageal squamous cell carcinoma SUPPLEMENTARY MATERIALS Supplementary Figure 1 : Ad-ATF/SOX2 up-regulated CDKN1A mRNA in lung and esophageal SCC cells more than Ad-shSOX2. qPCR analysis showed that Ad-ATF/SOX2 increased CDKN1A mRNA expression more significantly than Ad-shSOX2 48 hours after adenoviral infections in all kinds of cells indicated. Fold changes relative to the CDKN1A mRNA induced by Ad-null at the minimal MOI in each kinds of cells were represented. Results represent the mean ± SD (n = 3). Statistical analysis was performed using Student's t test (two-tailed, unpaired). Statistical significance was defined as * p < 0.01 vs Ad-null treated group at the same MOI; $ p < 0.01 vs Ad-shSOX2 treated group at the same MOI.
Immunoblot analysis shows Ad-shSOX2 and Ad-ATF/SOX2 increased little CDKN1A expression 48 hours after adenoviral infections in SOX2 negative lung SCC cells and normal human cells. (B) Ad-ATF/SOX2 did not significantly inhibit cell growth of HUVEC and NHLF cells that lack SOX2 expression compared to control (p > 0.01 vs Ad-null treated group). Cell viability was assessed 48 hours after adenoviral infection with a TC20 automated cell counter. Results represent the mean ± SD (n = 3).
Supplementary Figure 4:
Ad-ATF/SOX2 did not change mRNA expression of ABL1, RTN4 and KMT2B that contained highly similar sequence to the 19 bp target sequence of ATF/SOX2 in EBC2 cells. Nucleotide Blast revealed that Homo sapiens ABL proto-oncogene 1, non-receptor tyrosine kinase transcript variant a mRNA (ABL1, NM_005157.5), Homo sapiens reticulon 4 transcript variant 1 mRNA (RTN4, NM_020532.4) and Homo sapiens lysine methyltransferase 2B mRNA (KMT2B, NM_014727.2) had high-identity matched sequence to the 19 bp target sequence of ATF/SOX2 (more than 16 base-pair match with 100% identity and no sequence gaps). qPCR showed that their mRNA expression 48 hours after Ad-ATF/SOX2 infection was not significantly changed compared to that after Ad-null infection.
Supplementary Figure 5:
The other kinds of zinc finger based transcription factors did not alter SOX2 or CDKN1A expression in EBC2 lung squamous cells. Immunoblot showed that SOX2 and CDKN1A expression was not changed 72 hours after transfection with plasmid vectors that express the other kinds of zinc finger based transcription factors (pGFPZFN1.4-B2H, pGFPZFN2-B2H, pPIGAZFN-L1 and pPIGAZFN-R2 in EBC2 cells. Ctrl 1: pcDNA3.1, Ctrl 2: pST1374. Protein was isolated after puromycin selection as described in Materials and Methods section.
